 Corvus Pharmaceuticals Inc NASDAQ: CRVS is surging higher Friday on abnormally high volume. The stock might be trading higher following favorable data results by AstraZeneca PLC NASDAQ: AZN for patients with unresectable, stage 3 non-small cell lung cancer. 